Sangon Biotech: difference between revisions
Diff·revision 17 → 18·03:21, 23 Aug 2025
Difference between revision 17 and revision 18 of Sangon Biotech. 7 lines changed; the page grew by 592 bytes.
| Revision 17 — 03:08, 1 Aug 2025 BlindSampleBrid (talk) move a stray full stop inside the reference 11,547 bytes +1,893 | Revision 18 — 03:21, 23 Aug 2025 EndotoxinEd (talk) add the note that self-published material is usable only for what it states about itself 12,139 bytes +592 | ||
|---|---|---|---|
| 71 | '''The one check that needs no equipment''' is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See [[Lot traceability]]. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page. | 71 | '''The one check that needs no equipment''' is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See [[Lot traceability]]. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page. |
| 72 | 72 | ||
| + | 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. | |
| + | 74 | ||
| 73 | == Reception == | 75 | == Reception == |
| 74 | The PeptidePedia tally records 751 self-reported submissions to July 2026. Recurring themes are catalogue breadth and the documentary standard of the laboratory-reagent lines, which submissions describe as following the conventions of the reagent trade rather than those of the research-compound trade.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | 76 | The PeptidePedia tally records 751 self-reported submissions to July 2026. Recurring themes are catalogue breadth and the documentary standard of the laboratory-reagent lines, which submissions describe as following the conventions of the reagent trade rather than those of the research-compound trade.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} |
| ⋮ | ⋮ | ||
| 96 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | 98 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> |
| 97 | 99 | ||
| + | 100 | == Further reading == | |
| + | 101 | * [[Project:Vendor notability]] — the criteria under which this article exists, and what supplier articles may not contain. | |
| + | 102 | * [[Project:Sourcing guidelines]] — how test reports and community tallies are cited on this wiki. | |
| + | 103 | ||
| 98 | == See also == | 104 | == See also == |
| 99 | * [[Certificate of analysis]] | 105 | * [[Certificate of analysis]] |
| ⋮ | ⋮ | ||
| 103 | * [[Research use only]] | 109 | * [[Research use only]] |
| 104 | * [[Peptide supply chain]] | 110 | * [[Peptide supply chain]] |
| + | 111 | * [[Blind sampling]] | |
| 105 | 112 | ||
| 106 | {{DEFAULTSORT:Sangon Biotech}} | 113 | {{DEFAULTSORT:Sangon Biotech}} |